The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ARRAY BIOPHARMA INC | NOTE | 04269XAA3 | 18,140 | 22,534,000 | PRN | SOLE | 22,534,000 | 0 | 0 | ||
AKARI THERAPEUTICS PLC | SPONSORED ADR | 00972G108 | 1,292 | 92,303 | SH | SOLE | 92,303 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 10,533 | 2,098,302 | SH | SOLE | 2,098,302 | 0 | 0 | ||
ATYR PHARMA INC | COM | 002120103 | 295 | 74,959 | SH | SOLE | 74,959 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 462 | 15,766 | SH | SOLE | 15,766 | 0 | 0 | ||
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 8,587 | 473,123 | SH | SOLE | 473,123 | 0 | 0 | ||
CELATOR PHARMACEUTICALS INC | COM | 15089R102 | 10,479 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
CYTOKINETICS INC | COM | 23282W605 | 14,472 | 2,052,800 | SH | SOLE | 2,052,800 | 0 | 0 | ||
TARGACEPT INC | NOTE | 87611RAA6 | 669 | 669,166 | PRN | SOLE | 669,166 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 3,179 | 189,545 | SH | SOLE | 189,545 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 7,060 | 240,383 | SH | SOLE | 240,383 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 19,379 | 1,598,900 | SH | SOLE | 1,598,900 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 18,389 | 863,745 | SH | SOLE | 863,745 | 0 | 0 | ||
FLEX PHARMA INC | COM | 33938A105 | 6,318 | 575,925 | SH | SOLE | 575,925 | 0 | 0 | ||
FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 20,346 | 500,757 | SH | SOLE | 500,757 | 0 | 0 | ||
FORWARD PHARMA A/S | SPONSORED ADR | 34986J105 | 1,649 | 97,024 | SH | SOLE | 97,024 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS INC | COM | 37890U108 | 445 | 28,032 | SH | SOLE | 28,032 | 0 | 0 | ||
GALAPAGOS NV | SPONSORED ADR | 36315X101 | 10,317 | 246,691 | SH | SOLE | 246,691 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | COM | 46333X108 | 22,552 | 2,061,417 | SH | SOLE | 2,061,417 | 0 | 0 | ||
KINDRED BIOSCIENCES INC | COM | 494577109 | 4,943 | 1,432,765 | SH | SOLE | 1,432,765 | 0 | 0 | ||
KITE PHARMA INC | COM | 49803L109 | 6,887 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ARRAY BIOPHARMA INC | COM | 04269X905 | 1,534 | 520,000 | SH | Call | SOLE | 520,000 | 0 | 0 | |
CYTOKINETICS INC | COM | 23282W905 | 1,763 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | |
GILEAD SCIENCES INC | COM | 375558903 | 13,779 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
IMMUNOGEN INC | COM | 45253H901 | 2,552 | 299,500 | SH | Call | SOLE | 299,500 | 0 | 0 | |
IRONWOOD PHARMACEUTICALS INC | COM | 46333X908 | 3,282 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
SPDR SERIES TRUST S&P BIOTECH | COM | 78464A900 | 15,353 | 297,200 | SH | Call | SOLE | 297,200 | 0 | 0 | |
ZAFGEN INC | COM | 98885E903 | 67 | 10,000 | SH | Call | SOLE | 10,000 | 0 | 0 | |
SPARK THERAPEUTICS INC | COM | 84652J103 | 257 | 8,700 | SH | SOLE | 8,700 | 0 | 0 | ||
RETROPHIN INC | COM | 761299106 | 16,735 | 1,225,084 | SH | SOLE | 1,225,084 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 7,133 | 270,289 | SH | SOLE | 270,289 | 0 | 0 | ||
AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 7,070 | 521,366 | SH | SOLE | 521,366 | 0 | 0 | ||
LOXO ONCOLOGY INC | COM | 548862101 | 4,109 | 150,308 | SH | SOLE | 150,308 | 0 | 0 | ||
EDITAS MEDICINE INC | COM | 28106W103 | 3,037 | 87,921 | SH | SOLE | 87,921 | 0 | 0 | ||
NABRIVA THERAPTCS AG | SPONSORED ADR | 62957M104 | 6,342 | 707,817 | SH | SOLE | 707,817 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 6,804 | 510,829 | SH | SOLE | 510,829 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 9,984 | 2,465,286 | SH | SOLE | 2,465,286 | 0 | 0 |